Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Work In Process: 2024-2025

Historic Work In Process for CorMedix (CRMD) over the last 2 years, with Sep 2025 value amounting to $9.1 million.

  • CorMedix's Work In Process rose 78.61% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 78.61%. This contributed to the annual value of $3.5 million for FY2024, which is N/A change from last year.
  • Latest data reveals that CorMedix reported Work In Process of $9.1 million as of Q3 2025, which was up 74.61% from $5.2 million recorded in Q2 2025.
  • CorMedix's Work In Process' 5-year high stood at $9.1 million during Q3 2025, with a 5-year trough of $471,415 in Q1 2024.
  • For the 2-year period, CorMedix's Work In Process averaged around $4.2 million, with its median value being $4.3 million (2025).
  • Data for CorMedix's Work In Process shows a peak YoY spiked of 808.43% (in 2025) over the last 5 years.
  • Over the past 2 years, CorMedix's Work In Process (Quarterly) stood at $3.5 million in 2024, then surged by 78.61% to $9.1 million in 2025.
  • Its Work In Process stands at $9.1 million for Q3 2025, versus $5.2 million for Q2 2025 and $4.3 million for Q1 2025.